In an animation industry that increasingly feels overrun by consolidation, studio aversion to taking risks, and the proliferation of soulless automation, indie artists are launching their own studios ...

SAN FRANCISCO -- One new startup is called Recursive with an "e." Another is called Ricursive with an "i." They are trying to do the same thing: Build artificial intelligence that can improve itself ...

This is read by an automated voice. Please report any issues or inconsistencies here. Animation is the backbone of the film industry, boosting the global box office year after year. But such ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Cory Benfield discusses the evolution of ...

When it came to animated movies in 2025, the key takeaway was that franchise films were safe bets, while animated originals – at least theatrically – were potential minefields. This can be summed up ...

Remote workers at DreamWorks Animation, feature production staffers at Netflix Animation Studios and production workers on NBCUniversal’s “Ted” have voted to unionize with the Animation Guild (TAG) in ...

Multiple union drives launched in 2025 have paid off for the union, which had its latest victory at the National Labor Relations Board on Dec. 30. By Katie Kilkenny Labor & Media Reporter Several ...

Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...